General

Special Issues

Following special issues within this section are currently open for submissions:

• Functions of Cilia (Deadline: 15 December 2025)
• Physics of Cancer: How Mechanobiology Drives Cancer Progression (Deadline: 15 December 2025)
• The Cross-Talk Between Obesity and Metabolism (Deadline: 15 December 2025)
• AMPK: From Mechanisms to New Therapies (Deadline: 15 December 2025)
• Hormone Receptors in Cancers: From Molecular Insights to Clinical Applications (Deadline: 15 December 2025)
• Evaluation of the Properties and Effectiveness of Nutritional Factors Using In Vitro Assays, Including Cell Cultures and Organoids (Deadline: 20 December 2025)
• Advanced Research on Genomic Instability and Gene Expression in Developmental Disorders (Deadline: 20 December 2025)
• Targeting Thermogenesis in Metabolic Disorders: Novel Pharmacological and Lifestyle Interventions (Deadline: 20 December 2025)
• Molecular Insights into cAMP/PKA Pathway Regulation in Health and Disease (Deadline: 30 December 2025)
• Organelle Contact and Its Physiological Implications (Deadline: 31 December 2025)
• Standardization and Metrological Advancements in Cellular and Genomic Diagnostics for Cancer (Deadline: 31 December 2025)
• Recent Advances in Extracellular-Intracellular Communication and Cancer Therapies (Deadline: 31 December 2025)
• Cell Biology: State of the Art and Perspectives in Italy 2025 (Deadline: 31 December 2025)
• Genetic Mechanisms in Cellular Genomics and Therapeutics (Deadline: 31 December 2025)
• Hematopoietic Cell Lines as Models for Leukemia and Lymphoma (Deadline: 31 December 2025)
• New Insights into Gene Research and Therapy for Diabetes Mellitus (Deadline: 15 January 2026)
• The Evolving Landscape of Cell and Gene Therapy—Opportunities, Challenges and the Road Ahead (Deadline: 20 January 2026)
• Cellular Origin of Glioma: From Triggers to Treatments (Deadline: 20 January 2026)
• Gliomas: Molecular Insights, Next-Generation Therapies, and Precision Targeting (Deadline: 20 January 2026)
• Targeting Hallmarks of Cancer (Deadline: 25 January 2026)
• Metabolic Flexibility in Cancer: How Tumor Cells Adapt Their Metabolism to Growth and Spread (Deadline: 25 January 2026)
• Targeting Immune Dysfunction in Aging and Age-Related Diseases (Deadline: 25 January 2026)
• Tumor Immune Responsiveness in the Era of T Cell Immunotherapy (Deadline: 30 January 2026)
• CRISPR-Based Genome Editing in Translational Research—Third Edition (Deadline: 31 January 2026)
• Diagnostic and Therapeutic Application of Extracellular Vesicles (EV) (Deadline: 31 January 2026)
• The Role of Macrophages in Leishmaniasis: Current Perspective (Deadline: 31 January 2026)
• Examining the Cellular Biology of Adenovirus (Deadline: 31 January 2026)
• Single-Molecule Tracking for Live Cells (Deadline: 31 January 2026)
• Cell Behavior Under Blood Flow (Deadline: 31 January 2026)
• Genetics and Gene Regulation (Deadline: 31 January 2026)
• Gastrointestinal Disorders: Immunity and Inflammation (Deadline: 31 January 2026)
• New Perspectives of Respiratory Diseases: From Microbiome, Metabolism, and Immune Response (Deadline: 31 January 2026)
• Aquaporins at the Crossroads of Human Health and Disease (Deadline: 31 January 2026)
• Advances in the Role of Lipid Signaling in Diseases (Deadline: 5 February 2026)
• Decoding Cellular Organization Through Spatial Omics (Deadline: 10 February 2026)
• Epigenetic Mechanisms of Tumorigenesis (Deadline: 15 February 2026)
• Cancers and Metabolic Diseases—the Molecular Players in the Game (Deadline: 15 February 2026)
• GPCR Signaling in PDA: Calcium, cAMP, and Ras Activation in Pancreatic Ductal Adenocarcinoma (Deadline: 15 February 2026)
• Transient Receptor Potential (TRP) Channels and Health and Disease (Deadline: 20 February 2026)
• Elucidating Roles of Cell Adhesion Molecules in Health and Disease (Deadline: 20 February 2026)
• Advances in Molecular Research on Cancer Drug Targets and Drug Resistance (Deadline: 20 February 2026)
• Advances in T Cell Targeting for Cancer Immunotherapy (Deadline: 20 February 2026)
• Astrocytes: Roles and Functions in the Brain (Deadline: 21 February 2026)
• Molecular, Cellular and Biochemical Approaches of Anti-Cancer Drugs (Deadline: 25 February 2026)
• Molecular and Cellular Mechanisms of Ischemic Stroke (Deadline: 25 February 2026)
• Antigen Processing in Autoimmunity and Cancer—Mechanisms and Translational Perspectives (Deadline: 25 February 2026)
• Remyelination: From Molecular Mechanism to Therapy (Deadline: 25 February 2026)
• Molecular Mechanisms of Treatment Resistance in Prostate Cancer (Deadline: 25 February 2026)
• Research on Extracellular Vesicles in Health and Disease (Deadline: 25 February 2026)
• Molecular and Signaling Pathways in Pathological Changes of Esophageal, Gastric and Intestinal Epithelial Cells and Methods of Cell Protective Treatment (Deadline: 25 February 2026)
• Small Molecule Inhibitors: A New Era in Cancer Treatment (Deadline: 25 February 2026)
• Ion Channels in Cancer: From Molecular Mechanisms to Therapeutic Targets (Deadline: 27 February 2026)
• Pathogenesis of Alcohol-Associated Hepatitis and Its Therapies (Deadline: 27 February 2026)
• Cell Migration and Invasion (Deadline: 28 February 2026)
• Biomarkers in Human Diseases and Emerging Diagnostic Technologies for Their Identification and Application (Deadline: 28 February 2026)
• Going with the Flow and Beyond: Understanding Benign Blood Disorders and Their Underlying Mechanisms (Deadline: 28 February 2026)
• The Pivotal Role of Tumor Stem Cells in Glioblastoma: Second Edition (Deadline: 28 February 2026)
• The Lipid Metabolism and Signaling in Dry Eye Disease (Deadline: 28 February 2026)
• The Role of Pancreatic Beta-Cells in Obesity and Type 2 Diabetes (Deadline: 28 February 2026)
• Exploring New Treatments: Innovative Strategies Based on the Mechanism and Pathogenesis of Neurodevelopmental Disorders (Deadline: 28 February 2026)
• Cellular Mechanisms in Oral Cavity Homeostasis and Disease (Deadline: 28 February 2026)
• Ocular Surface and Adnexal Diseases: Molecular Mechanisms and Treatment Progresses (Deadline: 28 February 2026)
• Advanced Cell-Analyzing Technologies and Their Biosensing Applications (Deadline: 28 February 2026)
• Emerging Mechanisms and Therapeutic Strategies in Head and Neck Cancer (Deadline: 1 March 2026)
• Synaptic Senescence in Health and Neurodegeneration: Cellular and Molecular Mechanisms (Deadline: 9 March 2026)
• Gene Expression in Adipocytes During Obesity: Understanding Challenges and Future Prospects (Deadline: 10 March 2026)
• Targeting Tumor Suppressor Genes for Cancer Therapy (Deadline: 10 March 2026)
• Endothelial Dysfunction in Vascular Diseases (Deadline: 10 March 2026)
• α-Synuclein in Parkinson’s Disease (Deadline: 10 March 2026)
• Neural Governance of Gastrointestinal Motility (Deadline: 10 March 2026)
• Glioblastoma Cells: From Cellular and Molecular Mechanisms to Innovative Therapy—2nd Edition (Deadline: 15 March 2026)
• Targeting Metabolic Vulnerabilities to Selectively Eliminate Cancer Cells (Deadline: 15 March 2026)
• Glioblastoma Horizons: Exploring Mechanisms and Advancing Therapeutic Strategies (Deadline: 15 March 2026)
• Molecular Pathogenesis and Therapeutic Breakthroughs in Cutaneous Malignancies: From Melanoma to Lymphoma (Deadline: 15 March 2026)
• Molecular Mechanisms and Therapeutic Strategies of Macular Degeneration (Deadline: 19 March 2026)
• Highlights in Red Blood Cell Research (Deadline: 20 March 2026)
• Cell Biology: The State of the Art and Perspectives in Japan 2025 (Deadline: 20 March 2026)
• The Role of Cilia in Health and Diseases—2nd Edition (Deadline: 20 March 2026)
• Cancer Cell Signaling, Autophagy and Tumorigenesis (Deadline: 20 March 2026)
• Cell and Molecular Mechanisms of Cytogenesis (Deadline: 20 March 2026)
• Cellular and Molecular Mechanisms of Neurotoxicity (Deadline: 20 March 2026)
• Novel Insights into Endothelial Cells in Vascular Disease (Deadline: 20 March 2026)
• Novel Immunotherapies for Diffuse Large B-Cell Lymphoma (Deadline: 20 March 2026)
• From Signals to Shape: Molecular Control of Cellular Plasticity Through Epigenetic, Transcriptomic, and Immune Mechanisms (Deadline: 25 March 2026)
• Breaking the Balance: Cellular Stress, Proteostasis, Aggregates and Neurodegeneration (Deadline: 25 March 2026)
• Mitochondria: Multifaceted Regulators of Cell Death (Deadline: 25 March 2026)
• Ischemic Heart Disease: From Cellular Level to Clinical Approaches (Deadline: 25 March 2026)
• Cancer Stem Cells in Triple-Negative Breast Cancer (Deadline: 25 March 2026)
• Cell and Molecular Mechanisms of Bacterial Meningitis (Deadline: 25 March 2026)
• Molecular Mechanisms of Trophoblast Differentiation (Deadline: 25 March 2026)
• Neuroimaging of Cerebrovascular Diseases (Deadline: 30 March 2026)
• Novel Insights into Cancer Immune Responsiveness (Deadline: 30 March 2026)
• Mechanisms of miRNA Metabolism and Extracellular Transport (Deadline: 30 March 2026)
• Impact of Chronic Substance Exposure on Hematopoiesis and Immunity (Deadline: 30 March 2026)
• Molecular Mechanisms and Biomarker Development in Prostate Cancer (Deadline: 30 March 2026)
• Mechanisms and Dynamics in Cellular Adhesion in Development and Disease (Deadline: 31 March 2026)
• Ubiquitin Ligases: Key Regulators in Cellular Homeostasis and Disease (Deadline: 31 March 2026)
• Membrane Trafficking Components and Mechanisms in Bacterial, Viral or Fungal Infections (Deadline: 31 March 2026)
• The Challenges and Opportunities of Mesenchymal Stromal Cells in Regenerative Medicine (Deadline: 31 March 2026)
• GABA_A Receptor Dynamics: From Cellular Quality Control to Disease Mechanisms (Deadline: 31 March 2026)
• Advances in CAR Cell Therapies and Manufacturing (Deadline: 31 March 2026)
• Neurodegenerative Diseases and Related Proteins (Deadline: 31 March 2026)
• From Energy Metabolism to Disease: The Multifaceted Roles of Mitochondria (Deadline: 31 March 2026)
• Neurodevelopmental Factors of Autism Spectrum Disorder: Etiology to Therapy (Deadline: 31 March 2026)
• Cellular and Molecular Mechanisms of Alcohol-Induced Cellular/Organ Injury and Regeneration (Deadline: 31 March 2026)
• PI3K/AKT/mTOR Signaling Network in Human Health and Diseases, 3rd Edition (Deadline: 31 March 2026)
• Multi-Omics Technologies in Immunity Within Tumors (Deadline: 31 March 2026)
• Cellular and Molecular Insights into Gynecologic Tumors (Deadline: 31 March 2026)
• Hepatoblastoma: Molecular Mechanisms and Therapeutic Strategies (Deadline: 31 March 2026)
• From Liver Transplantation to Gene Therapy: A Therapeutic Revolution in Argininosuccinic Aciduria (Deadline: 31 March 2026)
• Cellular Mechanisms in Pregnancy and Foetal Development (Deadline: 31 March 2026)
• Lung Diseases: From Cellular and Molecular Mechanisms to Targeted Therapies (Deadline: 31 March 2026)
• Organelle Crosstalk: New Insights into Intracellular Communication and Dynamics (Deadline: 31 March 2026)
• Novel Biomarkers and Dose-Response Modifiers in Radiation Oncology and Nuclear Medicine: Molecular Insights for Personalized Therapy and Precision Medicine (Deadline: 31 March 2026)
• Glycolysis in Tumorigenesis: Mechanisms and Therapeutic Implications (Deadline: 1 April 2026)
• Evolution, Structure, and Functions of Apolipoproteins L (Deadline: 10 April 2026)
• New Tools to Address Old Challenges in Tolerogenic Cellular Therapies (Deadline: 10 April 2026)
• Cellular Mechanisms of Testosterone in Metabolic Disorders (Deadline: 13 April 2026)
• Yeast Stress Responses and Cell Death Regulation (Deadline: 15 April 2026)
• Advances in Zebrafish Disease Models (Deadline: 15 April 2026)
• Decoding Cancer Metabolism: Recent Insights and Future Directions (Deadline: 15 April 2026)
• Cell Biology of the Eye: Development, Disorders, and Repair (Deadline: 15 April 2026)
• Cellular and Molecular Mechanisms of Cell Death in Neurodegenerative Diseases (Deadline: 15 April 2026)
• Extracellular Vesicles in Chronic Obstructive Pulmonary Disease: A 2025 Update (Deadline: 15 April 2026)
• Advances in Annexin Biology (Deadline: 15 April 2026)
• Translational Aspects of Cell Signaling (Deadline: 15 April 2026)
• Cellular Metabolism and Hormonal Signaling in Colorectal Cancer: Biomarkers and Therapeutic Opportunities (Deadline: 15 April 2026)
• Cellular and Molecular Mechanisms Studies of the Adrenal Gland (Deadline: 15 April 2026)
• Sperm Biology and Reproductive Health—Second Edition (Deadline: 20 April 2026)
• Extracellular Vesicles and Exosomes: Novel Insight and Therapeutic Applications in Cancer (Deadline: 20 April 2026)
• Cellular and Molecular Mechanisms of Microglia/Macrophages in the Nervous System (Deadline: 20 April 2026)
• Signalling Mechanisms Regulating Cardiac Fibroblast Function (Deadline: 20 April 2026)
• Stress-Induced Acute Immune Activation and Its Biological Consequences (Deadline: 20 April 2026)
• New Mechanistic Insights and Novel Therapeutic Options for Pulmonary Vascular Disease (PVD) (Deadline: 20 April 2026)
• Cellular and Molecular Mechanisms of Idiopathic Pulmonary Fibrosis (Deadline: 20 April 2026)
• Regulation of Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) in Angiogenesis (Deadline: 25 April 2026)
• Molecular and Cellular Insights into Platelet Function, 2nd Edition (Deadline: 25 April 2026)
• Modulation of P2X Receptors: Emerging Implications for Cellular Signaling and Disease Management (Deadline: 30 April 2026)
• Advances in Bacterial Cell Biophysics: Metabolic Engineering and Host Interactions (Deadline: 30 April 2026)
• Mechanisms Underlying Cell Growth and Development (Deadline: 30 April 2026)
• Novel Therapies and Biomarkers for Rare Diseases (Deadline: 30 April 2026)
• The Role of Integrins and Small GTPases in Health and Disease (Deadline: 30 April 2026)
• Interleukin-1 Signaling in Cancer: Novel Mechanisms and Therapeutic Opportunities (Deadline: 30 April 2026)
• Advances in Liquid Biopsy for Early Detection and Monitoring of Cancer (Deadline: 30 April 2026)
• Molecular Mechanisms of Autophagy, Apoptosis and Senescence and Therapeutic Advances in Cancer Progression (Deadline: 30 April 2026)
• Glycosylation and Glycoproteins in Human Disease (Deadline: 30 April 2026)
• Advances in Neuropathology: Cellular, Molecular and Precision Mechanisms in Neurodegenerative Diseases (Deadline: 30 April 2026)
• Molecular Signaling and Mechanism on Vascular Remodeling (Deadline: 30 April 2026)
• Hematologic Diseases: From Cellular and Molecular Mechanisms to Therapies (Deadline: 30 April 2026)
• Molecular Mechanisms Underlying Inflammatory Pain (Deadline: 30 April 2026)
• Kidney Development: Cellular and Molecular Insights (Deadline: 30 April 2026)
• New Therapeutic Approaches to Cardiac Repair (Deadline: 30 April 2026)
• Noncoding RNAs: Immunity, Mechanisms, and Biomarker Potential (Deadline: 30 April 2026)
• Exploiting Stem Cell Pathways for Immune Protection (Deadline: 30 April 2026)
• Advancing Breast Cancer Research: Multi-Omics, AI, and Emerging Cellular Mechanisms (Deadline: 30 April 2026)
• Plasticity of Skeletal, Cardiac and Smooth Muscles in COPD: Repair and Remodeling (Deadline: 10 May 2026)
• Cellular Senescence and Transformation: Unraveling the Biological Links Between Aging and Cancer (Deadline: 10 May 2026)
• Thirty plus Years’ Journey—Painting the Molecular Picture of E-C Coupling (Deadline: 15 May 2026)
• Molecular and Translational Advances in Metastatic Breast Cancer Research (Deadline: 15 May 2026)
• Placenta in Tissue Engineering and Regeneration (Deadline: 15 May 2026)
• The Role of Light in Ocular Health and Disease (Deadline: 15 May 2026)
• Molecular Pathogenesis and Novel Therapeutic Strategies in Chordoma (Deadline: 15 May 2026)
• Conditional Programming of Cells, Advanced Computational Methods, and Intelligent Systems in Prostate Cancer Research (Deadline: 15 May 2026)
• Cellular and Molecular Basis of Sjögren’s Syndrome (Deadline: 20 May 2026)
• Regulation of Iron Homeostasis (Deadline: 20 May 2026)
• Basic Mechanisms and Emerging Therapeutic Strategies for Spinal Cord Injury (Deadline: 25 May 2026)
• Metabolic Regulation of Cell Behavior and Implications for Aging (Deadline: 25 May 2026)
• Brain Function and Structure: Mapping Complexity in Neuronal Cells (Deadline: 25 May 2026)
• Resistance of Hematological Malignancies and Solid Tumors to CAR T Cell Therapy (Deadline: 25 May 2026)
• Human DNA Replication/Repair Factors (Deadline: 25 May 2026)
• Therapeutic Targeting of Myeloid Cells in Tumor (Deadline: 30 May 2026)
• Cilia-Based New Discoveries: Ciliogenesis, Function, and Human Diseases (Deadline: 31 May 2026)
• Exploring the Structural and Functional Diversity of Proteins: Foundations of Life and Biological Complexity (Deadline: 31 May 2026)
• G Protein-Coupled Receptors and Diseases (Deadline: 31 May 2026)
• The Multifaceted Role of Molecular Chaperones in Cancer: Pro-Tumoral or Therapeutic Function (Deadline: 31 May 2026)
• Non-Coding RNAs as Regulators of Cellular Function and Disease (Deadline: 31 May 2026)
• Development and Characterization of Innovative In Vitro Models (Deadline: 31 May 2026)
• Sex Differences in Cardiovascular Structure and Function—from Mechanisms to Therapeutics (Deadline: 31 May 2026)
• Inflammatory Signaling and Vascular Dysfunction in Atherosclerosis (Deadline: 31 May 2026)
• Circadian Rhythms in Action: Cellular and Molecular Mechanisms Revealed by Model Organisms (Deadline: 31 May 2026)
• DNA Damage and Repair in Targeted Cancer Therapy (Deadline: 31 May 2026)
• Immunotherapy-Induced Cardiotoxicity: Unraveling the Immune Landscape of Myocarditis (Deadline: 31 May 2026)
• Cellular Responses to Heavy Metals: From Intestinal Uptake to Disease (Deadline: 31 May 2026)
• Extracellular Vesicles in Reproductive Communication: From Gametogenesis to Implantation (Deadline: 31 May 2026)
• Advances in Ion Channel Biology: From Molecular Mechanisms to Therapeutic Targets (Deadline: 31 May 2026)
• Epigenetic and Cellular Regulation in Hematologic Disorders (Deadline: 31 May 2026)
• Cellular and Molecular Mechanisms of Heart Development (Deadline: 31 May 2026)
• Skeletal Muscle Aging and Regeneration: Mitochondrial Health, Molecular Signaling, and Therapeutic Interventions (Deadline: 31 May 2026)
• Endometrial Cancer: From Molecular Mechanisms to Therapeutic Approaches (Deadline: 31 May 2026)
• Mitochondria Beyond Energy: Signaling, Immunity, and Cell Fate (Deadline: 31 May 2026)
• Decoding Heart Failure: From Mechanisms to Treatment (Deadline: 31 May 2026)
• Molecular Mechanisms and Therapeutic Strategies for Skeletal Muscle Disorders (Deadline: 31 May 2026)
• Molecular Mechanisms of Fibrosis in Chronic Liver Diseases (Deadline: 1 June 2026)
• Novel Insights into Developing Therapeutic Strategies for Neurological Disorders (Deadline: 15 June 2026)
• Regulation of Hormone Secretion from Islets in Health and Disease (Deadline: 15 June 2026)
• Bone and Soft Tissue Tumors: Molecular Mechanisms and Emerging Therapeutics (Deadline: 15 June 2026)
• Overcoming Resistance to Immune Checkpoint Inhibitors in Cancer: Mechanisms, Models, and Therapeutic Strategies (Deadline: 15 June 2026)
• Extracellular Vesicles Based Drug Delivery (Deadline: 25 June 2026)
• The Orchestration of Glial Cells in Health and Disease (Deadline: 25 June 2026)
• Cutaneous Regeneration and Tissue Engineering: From Hair Follicle Regeneration to Skin Restoration (Deadline: 25 June 2026)
• Inflammation and Atherosclerosis: Emerging Mechanisms, Biomarkers and Therapeutic Opportunities (Deadline: 25 June 2026)
• Novel Insights in Chronic Epilepsy—from Molecular Mechanisms to Future Therapies (Deadline: 25 June 2026)
• Systemic Sclerosis: Cellular Mechanisms, Innovative Diagnostics and Advanced Therapeutics (Deadline: 25 June 2026)
• The Function of Stem Cells in the Biomedical Applications (Deadline: 25 June 2026)
• MicroRNAs: Regulators of Cellular Fate (Deadline: 30 June 2026)
• Nuclear Pore Complex in Nanomedicine: Third Edition (Deadline: 30 June 2026)
• Emerging Topics in Cachexia (Deadline: 30 June 2026)
• Kidney and Lung Disorders: The Role of Tubular and Alveolar Epithelia in Health, Disease, Infection, and Organ Crosstalk (Deadline: 30 June 2026)
• Study on Immune Activity of Natural Products (Deadline: 30 June 2026)
• Protein and RNA Regulation in Cells (Deadline: 30 June 2026)
• Bone and Tooth Biology: Development and Regeneration (Deadline: 30 June 2026)
• Mitochondrial Dynamics and Remodelling (Deadline: 30 June 2026)
• Tau Pathobiology and Excitotoxicity in Neurodegeneration and Epilepsy (Deadline: 30 June 2026)
• Neural Stem Cells and Progenitors: Mechanisms of Neurogenesis and Regenerative Potential (Deadline: 30 June 2026)
• The Immunology of Allergy and Asthma (Deadline: 30 June 2026)
• Multifaceted Nature of Immune Responses to Viral Infection (Deadline: 30 June 2026)
• Translating Extracellular Vesicle Science (Deadline: 30 June 2026)
• Biochemical Interaction and Supramolecular Complexes of Receptors in Cell Membranes (Deadline: 8 July 2026)
• Tumor Stroma Interaction (Deadline: 15 July 2026)
• Inflammation in the Brain: From Molecular and Cellular Mechanisms to Therapeutic Strategies (Deadline: 15 July 2026)
• Novel Molecular Targets for the Treatment of Sleep Disorders (Deadline: 25 July 2026)
• Toxicology in Cells: Cellular Mechanisms, Molecular Responses, and Modern Models (Deadline: 30 July 2026)
• Advances in Adipocyte Biology Research and Their Relevance to Metabolic Health (Deadline: 31 July 2026)
• Immunometabolic Reprogramming in Diabetic Kidney Disease: The Interplay of Innate Immunity, Oxidative Stress, and Cellular Metabolism (Deadline: 31 July 2026)
• ALK Signaling Pathways in NSCLC: From Cell Biology to Therapeutic Insights (Deadline: 31 July 2026)
• Extracellular Vesicles: Drivers, Biomarkers and Therapeutics in Cardiovascular Disease (Deadline: 31 July 2026)
• Recent Advances in Vitamin D and K in Cancer (Deadline: 31 July 2026)
• Cell Therapies in Cancer Treatment (Deadline: 10 August 2026)
• Study on Ovarian Follicle Development (Deadline: 10 August 2026)
• Redox Regulation by Nrf2 in Health and Disease (Deadline: 30 August 2026)
• Gut Microbiota, Metabolites, and Immune Regulation in Gastrointestinal Diseases (Deadline: 31 August 2026)
• Novel Insights into G-Protein-Coupled Receptor Biology: From Structure to Signaling Regulation (Deadline: 31 August 2026)
• Lipid Homeostasis in Health and Disease (Deadline: 20 September 2026)
• Stem Cells and Metabolism in Acute Myeloid Leukemia: Mechanisms, Models, and Therapeutic Opportunities (Deadline: 25 September 2026)
• Stress Signaling and Cell Fate Determination: The Role of Mitochondria (Deadline: 30 September 2026)
• Heat Shock Proteins and Human Cancers—2nd Edition (Deadline: 30 September 2026)
• Role of Endothelial Progenitor Cells in Vascular Dysfunction (Deadline: 30 September 2026)
• Caveolae Function in Cell Membrane Dynamics and Signal Transduction (Deadline: 25 October 2026)
• Neurotoxicity: Focusing on Molecular and Cellular Mechanisms (Deadline: 31 October 2026)
• Current Status and Future Challenges of Liquid Biopsy—2nd Edition (Deadline: 1 October 2027)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Advances in Cell Culture and Tissue Engineering
• Animal Models of Retinal Degeneration
• Cell Biology in the United States: Latest Advances and Perspectives
• Cell-to-Cell Metabolic Cross-Talk in Physiology and Pathology—2nd Edition
• Current Understanding in Cancer Treatment and Monitoring Through Identification of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles
• Cutaneous Lymphoma Molecular Pathogenesis, Diagnosis and Management
• Exclusive Papers from Editorial Board Members and Invited Scholars in Cells
• Feature Papers in ‘Organelle Function’ (Closed)
• Gastrointestinal Disease: From Molecular and Cellular Mechanisms to Novel Therapeutics
• Glycosylation and Cell Biology
• Molecular Mechanisms of Exercise and Healthspan (Closed)
• Oxidative Stress in Human Health and Disease
• Regulation of Eukaryotic Cytochrome c Oxidase
• Tumor Metabolism and Therapy